| LRP1B altered in cohorts of …ALTERED_INderived26 of 26show fewer |
|---|
| → altered in cohorts of | Skin Basal Cell Carcinoma 197 / 293 cases (67 %) · ssm · bcc_unige_2016 | — | — | Skin Basal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Skin Squamous Cell Carcinoma 37 / 83 cases (45 %) · ssm · cscc_ucsf_2021 · largest of 3 cohorts | — | — | Skin Squamous Cell Carcinoma | 3 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Small Cell Carcinoma 51 / 120 cases (43 %) · ssm · sclc_ucologne_2015 | — | — | Lung Small Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Melanoma 57 / 144 cases (40 %) · ssm · mel_dfci_2019 · largest of 4 cohorts | — | — | Melanoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cutaneous Melanoma 182 / 469 cases (39 %) · ssm · skcm_tcga_gdc · largest of 9 cohorts | — | — | Cutaneous Melanoma | 9 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Adenocarcinomasubtype 201 / 566 cases (36 %) · ssm · luad_tcga_pan_can_atlas_2018 · largest of 9 cohorts | — | — | Lung Adenocarcinoma | 9 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Squamous Cell Carcinoma 171 / 484 cases (35 %) · ssm · lusc_tcga_pan_can_atlas_2018 · largest of 6 cohorts | — | — | Lung Squamous Cell Carcinoma | 6 | Observed | cbioportal | graph → |
| → altered in cohorts of | Lung Non-Small Cell Carcinoma 402 / 1,144 cases (35 %) · ssm · nsclc_tcga_broad_2016 · largest of 2 cohorts | — | — | Lung Non-Small Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Gastroesophageal Junction Adenocarcinoma 125 / 518 cases (24 %) · ssm · stes_tcga_pub | — | — | Gastroesophageal Junction Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Gastric Adenocarcinoma 104 / 478 cases (22 %) · ssm · stad_tcga · largest of 5 cohorts | — | — | Gastric Adenocarcinoma | 5 | Observed | cbioportal | graph → |
| → altered in cohorts of | Endometrial Carcinoma 99 / 517 cases (19 %) · ssm · ucec_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Endometrial Carcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Esophageal Adenocarcinoma 33 / 185 cases (18 %) · ssm · esca_tcga · largest of 4 cohorts | — | — | Esophageal Adenocarcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Renal Cell Carcinoma 28 / 158 cases (18 %) · ssm · rcc_iatlas_immotion150_2018 | — | — | Renal Cell Carcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Colon Adenocarcinoma 75 / 429 cases (17 %) · ssm · coad_tcga_gdc · largest of 2 cohorts | — | — | Colon Adenocarcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Head and Neck Squamous Cell Carcinoma 85 / 515 cases (17 %) · ssm · hnsc_tcga_pan_can_atlas_2018 · largest of 4 cohorts | — | — | Head and Neck Squamous Cell Carcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Rectal Adenocarcinoma 24 / 155 cases (15 %) · ssm · read_tcga_gdc | — | — | Rectal Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | B-Cell Non-Hodgkin Lymphoma 96 / 755 cases (13 %) · ssm · mbn_mdacc_2013 · largest of 2 cohorts | — | — | B-Cell Non-Hodgkin Lymphoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Hepatocellular Carcinoma 59 / 494 cases (12 %) · ssm · hcc_clca_2024 · largest of 4 cohorts | — | — | Hepatocellular Carcinoma | 4 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cervical Squamous Cell Carcinoma 33 / 291 cases (11 %) · ssm · cesc_tcga_pan_can_atlas_2018 · largest of 2 cohorts | — | — | Cervical Squamous Cell Carcinoma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Colorectal Adenocarcinoma 105 / 1,015 cases (10 %) · ssm · crc_sysucc_2022 · largest of 6 cohorts | — | — | Colorectal Adenocarcinoma | 6 | Observed | cbioportal | graph → |
| → altered in cohorts of | Cholangiocarcinoma 39 / 417 cases (9.4 %) · ssm · chol_icgc_2017 | — | — | Cholangiocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Bladder Urothelial Carcinoma 40 / 474 cases (8.4 %) · ssm · blca_msk_tcga_2020 · largest of 6 cohorts | — | — | Bladder Urothelial Carcinoma | 6 | Observed | cbioportal | graph → |
| → altered in cohorts of | Multiple Myeloma 73 / 961 cases (7.6 %) · ssm · MMRF-COMMPASS | — | — | Multiple Myeloma | 1 | Observed | gdc | graph → |
| → altered in cohorts of | Diffuse Glioma 41 / 629 cases (6.5 %) · ssm · difg_glass · largest of 2 cohorts | — | — | Diffuse Glioma | 2 | Observed | cbioportal | graph → |
| → altered in cohorts of | Pancreatic Adenocarcinoma 22 / 383 cases (5.7 %) · ssm · paad_qcmg_uq_2016 | — | — | Pancreatic Adenocarcinoma | 1 | Observed | cbioportal | graph → |
| → altered in cohorts of | Prostate Adenocarcinoma 54 / 1,013 cases (5.3 %) · ssm · prad_p1000 · largest of 2 cohorts | — | — | Prostate Adenocarcinoma | 2 | Observed | cbioportal | graph → |